Skip to content
10-Q

Quarterly Report

AVIDITY BIOSCIENCES, INC.

0001599901-25-000106

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 24, 2025 120.54M sh
Shares Diluted Q1 2025 · Mar 31, 2025 129.23M sh
Shares Diluted Q1 2025 · Mar 31, 2024 87.21M sh
Capex Q1 2025 · Mar 31, 2025 $3.75M
Capex Q1 2025 · Mar 31, 2024 $915K
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$124.83M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$70.38M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $254.2M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $219.87M
Stockholders Equity Q1 2025 · Mar 31, 2025 $1.33B
Stockholders Equity Q1 2025 · Dec 31, 2024 $1.42B
Stockholders Equity Q1 2025 · Mar 31, 2024 $830.9M
Stockholders Equity Q1 2025 · Dec 31, 2023 $500.76M
Current Liabilities Q1 2025 · Mar 31, 2025 $84.87M
Current Liabilities Q1 2025 · Dec 31, 2024 $98.02M
Total Liabilities Q1 2025 · Mar 31, 2025 $130.35M
Total Liabilities Q1 2025 · Dec 31, 2024 $138.94M
Current Assets Q1 2025 · Mar 31, 2025 $1.43B
Current Assets Q1 2025 · Dec 31, 2024 $1.54B
Total Assets Q1 2025 · Mar 31, 2025 $1.46B
Total Assets Q1 2025 · Dec 31, 2024 $1.56B
Eps Diluted Q1 2025 · Mar 31, 2025 −$0.90
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.79
Eps Basic Q1 2025 · Mar 31, 2025 −$0.90
Eps Basic Q1 2025 · Mar 31, 2024 −$0.79
Sga Expense Q1 2025 · Mar 31, 2025 $33.6M
Sga Expense Q1 2025 · Mar 31, 2024 $13.9M
Rd Expense Q1 2025 · Mar 31, 2025 $99.49M
Rd Expense Q1 2025 · Mar 31, 2024 $66.83M
Net Income Q1 2025 · Mar 31, 2025 −$115.77M
Net Income Q1 2025 · Mar 31, 2024 −$68.86M
Operating Income Q1 2025 · Mar 31, 2025 −$131.52M
Operating Income Q1 2025 · Mar 31, 2024 −$77.19M
Revenue Q1 2025 · Mar 31, 2025 $1.57M
Revenue Q1 2025 · Mar 31, 2024 $3.54M